We are live on ! Find out more
OCGN icon

Ocugen

23 hedge funds and large institutions have $19.9M invested in Ocugen in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,343% more capital inflows, than outflows

Capital inflows: $11.1M | Capital outflows: $454K

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

10% more funds holding

Funds holding: 21 → 23 (+2)

7.82% more ownership

Funds ownership: 45.98% → 53.81% (+7.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OCGN Hedge Fund Activity: Q4 2016 in Review

23 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q4 2016, worth a combined $19.9M — down 15% from $23.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OCGN positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Armistice Capital, adding an estimated $2.31M. The largest seller was Palo Alto Investors, cutting an estimated $351K.

  • 23 institutional investors held Ocugen (OCGN) as of Q4 2016, up from 21 in Q3 2016.
  • Funds reported $19.9M of Ocugen stock for Q4 2016, down 15% quarter-over-quarter.
  • 4 funds opened new Ocugen positions in Q4 2016 and 2 closed out, a net change of +2 holders.
  • The largest Ocugen buyer in Q4 2016 was Armistice Capital, an estimated $2.31M added.
  • The largest Ocugen seller in Q4 2016 was Palo Alto Investors, an estimated $351K sold.

Based on aggregated 13F filings for Q4 2016.